文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

感染性休克期间血小板减少的机制:内源性脓毒症介质的多元聚类分析

Mechanisms of Thrombocytopenia During Septic Shock: A Multiplex Cluster Analysis of Endogenous Sepsis Mediators.
PubMed 文献 · Shock · 2018-01-01
一句话结论感染性休克患者血小板减少发生率达55%,与内皮功能障碍/凝血病、血液稀释及血小板生成改变等多重机制相关。

这项前瞻性观察研究纳入60例感染性休克患者,采用多元分析检测27种内源性介质,评估血小板减少(血小板绝对计数<100 G/L或第一周内相对下降50%)的相关因素。55%的患者发生血小板减少,这些患者更易出现肺外感染和菌血症,弥散性血管内凝血发生率达81%。无偏层次聚类识别出五个介质集群:血小板活化标志物(如血小板反应蛋白-1)与血小板计数正相关;炎症标志物(如肿瘤坏死因子α和热休克蛋白70)及内皮功能障碍标志物(如细胞间黏附分子-1和血管细胞黏附分子-1)与血小板计数负相关;血小板生成生长因子(如血小板生成素)也与血小板计数负相关。血液稀释替代指标(如低蛋白血症和较高的液体平衡)亦与血小板减少相关。结论认为感染性休克时血小板减少似乎涉及多重机制。

要点

  • 感染性休克患者血小板减少(血小板计数<100 G/L或第一周内相对下降50%)发生率为55%(33/60)。
  • 合并血小板减少者更易出现肺外感染和菌血症,弥散性血管内凝血发生率达81%。
  • 内皮功能障碍/凝血病标志物(如细胞间黏附分子-1、血管细胞黏附分子-1)及炎症标志物(如肿瘤坏死因子α、热休克蛋白70)与血小板计数负相关。
  • 血小板活化标志物(如血小板反应蛋白-1)与血小板计数正相关,而血小板生成素等血小板生成生长因子与血小板计数负相关。
  • 血液稀释替代指标(低蛋白血症、较高液体平衡)与血小板减少相关。

适用人群与场景

  • 感染性休克成人患者,排除了有血小板减少风险的基础疾病者(血液系统恶性肿瘤、化疗、肝硬化、慢性心力衰竭)。

诊断标准与关键阈值

  • 血小板减少定义为血小板绝对计数<100 G/L或感染性休克第一周内血小板计数相对下降50%。

研究设计与关键结果

  • 前瞻性观察研究,纳入60例感染性休克患者,33例(55%)发生血小板减少。
  • 血小板减少患者更易出现肺外感染和菌血症,弥散性血管内凝血发生率81%。
  • 无偏层次聚类识别出五个脓毒症介质集群:血小板活化标志物(如血小板反应蛋白-1)与血小板计数正相关;炎症标志物(如肿瘤坏死因子α、热休克蛋白70)及内皮功能障碍标志物(如细胞间黏附分子-1、血管细胞黏附分子-1)与血小板计数负相关;血小板生成生长因子(如血小板生成素)与血小板计数负相关。
  • 血液稀释替代指标(低蛋白血症、较高液体平衡)与血小板减少相关。

证据类型、等级与局限

  • 证据类型:前瞻性观察研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为感染性休克时血小板减少似乎涉及内皮功能障碍/凝血病、血液稀释和血小板生成改变等多重机制。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Thrombocytopenia is a common feature of sepsis and may involve various mechanisms often related to the inflammatory response. This study aimed at evaluating factors associated with thrombocytopenia during human septic shock. In particular, we used a multiplex analysis to assess the role of endogenous sepsis mediators.

METHODS: Prospective, observational study. Thrombocytopenia was defined as an absolute platelet count <100 G/L or a 50% relative decrease in platelet count during the first week of septic shock. Plasma concentrations of 27 endogenous mediators involved in sepsis and platelet pathophysiology were assessed at day-1 using a multi-analyte Milliplex human cytokine kit. Patients with underlying diseases at risk of thrombocytopenia (hematological malignancies, chemotherapy, cirrhosis, and chronic heart failure) were excluded.

RESULTS: Thrombocytopenia occurred in 33 (55%) of 60 patients assessed. Patients with thrombocytopenia were more prone to present with extrapulmonary infections and bacteremia. Disseminated intravascular coagulation was frequent (81%) in these patients. Unbiased hierarchical clustering identified five different clusters of sepsis mediators, including one with markers of platelet activation (e.g., thrombospondin-1) positively associated with platelet count, one with markers of inflammation (e.g., tumor necrosis factor alpha and heat shock protein 70), and endothelial dysfunction (e.g., intercellular adhesion molecule-1 and vascular cell adhesion molecule-1) negatively associated with platelet count, and another involving growth factors of thrombopoiesis (e.g., thrombopoietin), also negatively associated with platelet count. Surrogates of hemodilution (e.g., hypoprotidemia and higher fluid balance) were also associated with thrombocytopenia.

CONCLUSION: Multiple mechanisms seemed involved in thrombocytopenia during septic shock, including endothelial dysfunction/coagulopathy, hemodilution, and altered thrombopoiesis.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Bedet A, Razazi K, Boissier F, et al. Mechanisms of Thrombocytopenia During Septic Shock: A Multiplex Cluster Analysis of Endogenous Sepsis Mediators. Shock. 2018. PMID: 29028771. doi:10.1097/SHK.0000000000001015

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。